The University of Chicago Header Logo

Connection

John Fung to Lymphocyte Activation

This is a "connection" page, showing publications John Fung has written about Lymphocyte Activation.
Connection Strength

0.573
  1. Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2012 Feb; 53(2):959-66.
    View in: PubMed
    Score: 0.081
  2. Tacrolimus and transplantation: a decade in review. Transplantation. 2004 May 15; 77(9 Suppl):S41-3.
    View in: PubMed
    Score: 0.047
  3. Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells. Transplant Proc. 1999 Feb-Mar; 31(1-2):784.
    View in: PubMed
    Score: 0.033
  4. Hepatic Stellate Cells Directly Inhibit B Cells via Programmed Death-Ligand 1. J Immunol. 2016 Feb 15; 196(4):1617-25.
    View in: PubMed
    Score: 0.027
  5. Hepatic Stellate Cells Inhibit T Cells through Active TGF-ß1 from a Cell Surface-Bound Latent TGF-ß1/GARP Complex. J Immunol. 2015 Sep 15; 195(6):2648-56.
    View in: PubMed
    Score: 0.026
  6. Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation. Transplant Proc. 1995 Feb; 27(1):520-1.
    View in: PubMed
    Score: 0.025
  7. Cytidine potentiates the inhibitory effect of brequinar sodium on xeno-MLR, antibody production, and concordant hamster to rat cardiac xenograft survival. Ann N Y Acad Sci. 1993 Nov 30; 696:227-34.
    View in: PubMed
    Score: 0.023
  8. Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. Transplant Proc. 1993 Feb; 25(1 Pt 1):781-3.
    View in: PubMed
    Score: 0.022
  9. Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. Transplant Proc. 1993 Feb; 25(1 Pt 1):704-5.
    View in: PubMed
    Score: 0.022
  10. The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes. Immunology. 2007 Feb; 120(2):251-60.
    View in: PubMed
    Score: 0.014
  11. Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells. Transplant Proc. 2007 Jan-Feb; 39(1):281-2.
    View in: PubMed
    Score: 0.014
  12. Functional studies of in vivo committed lymphocytes propagated from organ transplants. Prog Clin Biol Res. 1986; 211:59-73.
    View in: PubMed
    Score: 0.013
  13. Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol. 1985 Nov; 14(3):287-94.
    View in: PubMed
    Score: 0.013
  14. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. Transpl Immunol. 2005 Jun; 14(2):109-16.
    View in: PubMed
    Score: 0.013
  15. Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients. Transplantation. 2005 Feb 27; 79(4):451-9.
    View in: PubMed
    Score: 0.013
  16. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004 Dec; 40(6):1312-21.
    View in: PubMed
    Score: 0.012
  17. Ex vivo priming of naïve T cells into EBV-specific Th1/Tc1 effector cells by mature autologous DC loaded with apoptotic/necrotic LCL. Am J Transplant. 2003 Nov; 3(11):1369-77.
    View in: PubMed
    Score: 0.011
  18. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant. 2003 Apr; 17(2):77-88.
    View in: PubMed
    Score: 0.011
  19. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.
    View in: PubMed
    Score: 0.011
  20. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation. 2001 Oct 27; 72(8):1423-32.
    View in: PubMed
    Score: 0.010
  21. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. Ther Drug Monit. 2001 Aug; 23(4):354-62.
    View in: PubMed
    Score: 0.010
  22. Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol. 2001 Jun 15; 166(12):7042-52.
    View in: PubMed
    Score: 0.010
  23. Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol. 2001 May 01; 166(9):5619-28.
    View in: PubMed
    Score: 0.010
  24. Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Transplant Proc. 2001 Feb-Mar; 33(1-2):235.
    View in: PubMed
    Score: 0.009
  25. Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease. Transplant Proc. 2000 Aug; 32(5):1032-3.
    View in: PubMed
    Score: 0.009
  26. Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation. 1999 Nov 15; 68(9):1402-9.
    View in: PubMed
    Score: 0.009
  27. Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. Transplant Proc. 1999 Feb-Mar; 31(1-2):797.
    View in: PubMed
    Score: 0.008
  28. Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. Transplant Proc. 1998 Mar; 30(2):521.
    View in: PubMed
    Score: 0.008
  29. Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):1310.
    View in: PubMed
    Score: 0.007
  30. An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv Exp Med Biol. 1997; 417:269-74.
    View in: PubMed
    Score: 0.007
  31. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996 Sep 15; 62(5):659-65.
    View in: PubMed
    Score: 0.007
  32. Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity. J Clin Invest. 1996 Jan 01; 97(1):217-25.
    View in: PubMed
    Score: 0.007
  33. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15; 58(1):1-8.
    View in: PubMed
    Score: 0.006
  34. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells. Am J Pathol. 1993 Jul; 143(1):85-98.
    View in: PubMed
    Score: 0.006
  35. Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect. Transplant Proc. 1991 Dec; 23(6):2957-8.
    View in: PubMed
    Score: 0.005
  36. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes. Hepatology. 1991 Feb; 13(2):239-46.
    View in: PubMed
    Score: 0.005
  37. Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. Transplant Proc. 1990 Feb; 22(1):106-9.
    View in: PubMed
    Score: 0.004
  38. Analysis of T lymphocytes infiltrating human hepatic allografts. Transplant Proc. 1987 Feb; 19(1 Pt 3):2470-3.
    View in: PubMed
    Score: 0.004
  39. Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. J Heart Transplant. 1985 Jul-Aug; 4(4):417-21.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.